Histopathology as a key to identify Sezary syndrome in patient with clinical erythroderma
Abstract
Sezary syndrome (SS) is a rare and aggressive variant of cutaneous T-cell lymphoma (CTCL), characterized by clonal proliferation of malignant T lymphocytes with skin erythroderma. The incidence of CTCL in the United States from 2000 to 2010 reached 10 cases per million people per year, accounts for only 3% of all cases of cutaneous lymphoma. In Indonesia, lymphoma ranks sixth in terms of malignancies, alongside Hodgkin lymphoma and leukemia. We reported a case of 56 y.o. woman presented with blistering lesions that turned into wounds all over her body. Skin biopsy examination revealed characteristic histopathological features, including basket weave-type orthokeratosis, focal parakeratosis, focal acanthosis, and epidermotropism of atypical lymphoid cells with cerebriform nuclei (Sezary cells). Immunohistochemical examination using CD3, CD4, and CD8 showed positive staining in the membrane and cytoplasm of tumor cells within the dermis and epidermis. Sezary syndrome is characterized by clonal expansion of T-helper memory cells in the skin. Histopathology and immunohistochemistry could not differentiate SS from mycosis fungoides. However, histopathological examination could distinguish SS from other differential diagnoses. The diagnosis of SS can be established based on the triad of 1) generalized exfoliative dermatitis involving more than 80% of the body surface area, 2) lymphadenopathy, and 3) the presence of 5% or more malignant T-cells with cerebriform nuclei (Sezary or Lutzner cells) in peripheral blood lymphocytes. In conclusion, we present a case of SS, diagnosed based on the patient's history, physical examination, peripheral blood examination, histopathology, and immunohistochemistry.
References
Bagot M, Stadler R. Cutaneous Lymphoma. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al. editors. Fitzpatrick’s Dermatology, 9ed. New York, NY: McGraw-Hill Education; 2019.
Jonak C, Tittes J, Brunner PM, Guenova E. Mycosis fungoides and Sézary syndrome. J Dtsch Dermatol Ges 2021; 19(9):1307-34.
https://doi.org/10.1111/ddg.14610
Klemke CD, Booken N, Weiss C, Nicolay JP, Goerdt S, Felcht M, et al. Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: A European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases. Br J Dermatol 2015; 173(1):93-105.
https://doi.org/10.1111/bjd.13832
Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127(20):2375-90.
https://doi.org/10.1182/blood-2016-01-643569
Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, et al. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017. Eur J Cancer 2017; 77:57-74.
https://doi.org/10.1016/j.ejca.2017.02.027
Miyashiro D, Torrealba MP, Manfrere KC, Pereira J, Sato MN, Sanches JA. Double-positive CD4 and CD8 Sézary syndrome. JAAD Case Rep 2017; 3(6):485-8.
https://doi.org/10.1016/j.jdcr.2017.06.036
Nagler AR, Samimi S, Schaffer A, Vittorio CC, Kim EJ, Rook AH. Peripheral blood findings in erythrodermic patients: Importance for the differential diagnosis of Sézary syndrome. J Am Acad Dermatol 2012; 66(3):503-8.
https://doi.org/10.1016/j.jaad.2011.06.014
Hristov AC, Tejasvi T, Wilcox RA. Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk‐stratification, and management. Am J Hematol 2019; 94(9):1027-41.
https://doi.org/10.1002/ajh.25577
Foss FM, Girardi M. Mycosis fungoides and Sezary syndrome. Hematol Oncol Clin North Am 2017; 31(2):297-315.
https://doi.org/10.1016/j.hoc.2016.11.008
Punuru TR, Subashchandrabose P, Srinivasan C. Sezary syndrome- A case report. International Archives of Integrated Medicine 2017; 4(10): 262-5.
Larocca C, Kupper T. Mycosis fungoides and Sézary syndrome: An update. Hematol Oncol Clin North Am 2019; 33(1):103-20.
https://doi.org/10.1016/j.hoc.2018.09.001
Kamijo H, Miyagaki T, Norimatsu Y, Shishido‐Takahashi N, Kuzumi A, Asano Y, et al. Sézary syndrome without erythroderma: A case report and review of published work. J Dermatol 2019; 46(1):61-4.
https://doi.org/10.1111/1346-8138.14692
Lynoora ER, Rahmadewi R. Sezary syndrome mimicking generalized psoriasis vulgaris. Indonesian Journal of Tropical and Infectious Disease 2016; 6(3):59.